Chemical Compound
Loxapine Succinate; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine butanedioate; Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine; Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-, butanedioate; 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f][1,4]oxazepine succinate; CL 71563; Daxolin; Loxapac; Loxitane; Loxitane Capsules
CAS Registry Number
27833-64-3
Primary record
Loxapine Succinate; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine butanedioate; Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine; Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-, butanedioate; 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f][1,4]oxazepine succinate; CL 71563; Daxolin; Loxapac; Loxitane; Loxitane Capsules
- 库存
- 6,500 克
- 纯度
- 98.2 %
- CAS
- 27833-64-3
化合物标识与属性
- CAS
- 27833-64-3
- PubChem CID
- 71399
- SMILES
- CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O
- Canonical SMILES
- CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.O=C(O)CCC(=O)O
名称与同义词
- Loxapine succinate
- Loxapac
- Loxitane
- Loxapine succinate salt
- Cloxazepin
- Daxolin
- 27833-64-3
- Lederle
- Loxapine, Succinate
- loxapine
- Oxilapine
- Adasuve
- Loxapine (succinate)
- Loxapinsuccinate
- Loxipine Succinate
- Staccato-loxapine
- Loxapine,succinate
- Loxapine.succinate
- Loxitane (TN)
- Loxapinesuccinatesalt
- Prestwick_304
- Succinate, Loxapine
- X59SG0MRYU
- Loxapine succinate [USAN]
- UNII-X59SG0MRYU
- RefChem:58498
- Lopac-L-106
- AC1Q5VQU
- Opera_ID_1518
- CCRIS 1917
- Loxapine succinate (USP)
- C22H24ClN3O5
- DTXSID3045227
- MLS000069383
- CL 71563
- C18H18ClN3O
- Loxapine succinate [USAN:USP]
- SCHEMBL41643
- DTXCID1025227
- MAPROTILINEHYDROCHLORIDE
- MLS000758291
- MLS001146961
- MLS001401432
- MLS002222201
- NSC-759578
- SPECTRUM2300242
- EINECS 248-682-0
- Loxapine succinate salt, solid
- REGID_for_CID_71399
- MFCD00069298
- AC1L2G38
- CHEBI:6549
- orb1308691
- LOXAPINE SUCCINATE [MI]
- CHEMBL1201155
- CL-71563
- SCHEMBL29414130
- SCHEMBL30201498
- CTK4G0318
- ERK5-2O08
- Loxapine (succinate) (Standard)
- AOB5330
- C18H18ClN3O.C4H6O4
- CPD000058470
- GLXC-06117
- HMS1568K06
- HMS1922L14
- HMS2051E05
- HMS2093N20
- HMS2095K06
- HMS2232N05
- HMS3262O21
- HMS3374F02
- HMS3393E05
- HMS3652O10
- HMS3712K06
- HMS3885H03
- HMS5082M10
- HY-17390AR
- LOXAPINE SUCCINATE [VANDF]
- Pharmakon1600-02300242
- LOXAPINE SUCCINATE [MART.]
- CID71399
- LOXAPINE SUCCINATE [USP-RS]
- LOXAPINE SUCCINATE [WHO-DD]
- MSK11209
- SUM-3170
- Tox21_110311
- Tox21_500720
- AR-1E0046
- AZ-004
- AZ-104
- CCG-39497
- EBC-12876
- HY-17390A
- NCGC00016160-02
- NSC759578
- s4086
- SMR000058470
- AKOS015994711
- Tox21_110311_1
- CS-4285
- FL33800
- KS-1083
- LP00720
- NC00011
- NSC 759578
- VA11204
- CAS-27833-64-3
- LOXAPINE SUCCINATE [ORANGE BOOK]
- Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)
- NCGC00016160-01
- NCGC00016160-03
- NCGC00016160-04
- NCGC00016160-05
- NCGC00021145-11
- NCGC00094068-01
- NCGC00094068-02
- NCGC00094068-03
- NCGC00261405-01
- AC-37650
- CL-62362
- DA-55019
- LOXAPINE SUCCINATE [USP MONOGRAPH]
- O287
- SAM001247061
- C18-H18-Cl-N3-O.C4-H6-O4
- LS-147408
- B1783
- EU-0100720
- FT-0653022
- L-106
- NS00084038
- S-805
- SW196603-4
- VU0239541-8
- D00794
- F14786
- EN300-6477859
- 833L643
- A819208
- SR-01000002971
- SR-01000002971-2
- SR-01000002971-6
- SR-01000002971-9
- Loxapine.succinate, 1mg/ml in Methanol (as free base)
- Q27107236
- Z2756516768
- 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1)
- 2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine succinate
- 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f][1,4]oxazepine succinate
- 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine, Succinate
- 2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine succinate
- 2-Chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepinesuccinate
- Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1)
- Lidocaine succinate, 98%, a 5-HT inhibitor; dopamine receptor - 1G 1g
- Loxapine succinate, United States Pharmacopeia (USP) Reference Standard
- Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1)
- Succinic acid, compound with 2-chloro-11-(4-methylpiperazin-1-yl)dibenz(b,f)(1,4)oxazepine (1:1)
- 2-Chloro-11-(4-methyl-1- piperazinyl)-dibenz[b,f][1,4]- oxazepine succinate
- 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine Succinate(1:1)
- 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine;succinic acid
- Butanedioic acid--2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine (1/1)
- butanedioic acid; 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
- butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
- 13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene; butanedioic acid
- 248-682-0
- 28664-37-1
- Butanedioic Acid, compound with 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine(1:1)
- Loxapine Succinate; 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine butanedioate; Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine; Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-, butanedioate; 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz[b,f][1,4]oxazepine succinate; CL 71563; Daxolin; Loxapac; Loxitane; Loxitane Capsules
- Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)
- Succinic acid, compound with 2-chloro-11-(4-methylpiperazin-1-yl)dibenz[b,f][1,4]oxazepine (1:1)